"10.1371_journal.pone.0020700","plos one","2011-06-06T00:00:00Z","Thi-Mai Anh Dao; Aurélie Waget; Pascale Klopp; Matteo Serino; Christelle Vachoux; Laurent Pechere; Daniel J Drucker; Serge Champion; Sylvain Barthélemy; Yves Barra; Rémy Burcelin; Eric Sérée","Institut National de la Santé et de la Recherche Médicale U1048, Institut de recherche sur les Maladies Métaboliques et Cardiovasculaire, I2MC, Toulouse, France; Université de Toulouse, UPS, Institut des Maladies Métaboliques et Cardiovasculaires (I2 MC), Hôpital de Rangueil, Toulouse, France; Institut National de la Recherche Agronomique 1260, Faculté de Pharmacie, Marseille, France; ENTERONOVA SAS, Incubateur Midi-Pyrennées, Toulouse, France; Department of Medicine, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada; YVERY SARL, Marseille, France","Conceived and designed the experiments: RB ES. Performed the experiments: T-MAD AW PK MS CV LP SC SB. Analyzed the data: T-MAD RB ES MS YB DJD. Contributed reagents/materials/analysis tools: RB ES YB. Wrote the paper: T-MAD RB ES YB DJD SC.","The authors have read the journal's policy and have the following conflicts: Laurent Pechere and Sylvain Barthelemy have a duality of interest with ENTERONOVA and YVERY Cosmetics, because they are employed by the above mentioned companies. Rémy Burcelin and Eric Sérée have a duality of interest with ENTERONOVA as they have a consultancy mission. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","06","Thi-Mai Anh Dao","TMAD",12,TRUE,2,8,6,6,TRUE,TRUE,FALSE,0,NA,FALSE
